The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...

[2] Good evidence exists for the use of anti-EGF receptor (EGFR) monoclonal antibody treatment as part of first-line combination chemotherapy including infusional 5-fluorouracil and for third-line ...

Most of the currently promising compound groups belong either to the class of EGFR inhibitors (e.g., cetuximab ... locally advanced HPV/p16-negative HNSCC tumors with or without the hypoxic ...

The first patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) have been enrolled in the phase ... It combines an epidermal growth factor receptor (EGFR)-directed ...

This second BTD designation follows the initial receipt of BTD and Fast Track designation for petosemtamab for the treatment of patients with r/m HNSCC whose disease has ... the epidermal growth ...

EGFR-positive lung cancer is a type of non-small cell lung cancer (NSCLC). It can cause symptoms such as breathing problems and hoarseness. Therapy that targets the mutation, such as EGFR ...

Mian Kamal Khalid, MD: I use Caris [Life Sciences] next-generation sequencing (NGS) testing and PD-L1 done as an immunohistochemistry test ... But I also think that the type of EGFR mutation may be ...

This second BTD designation follows the initial receipt of BTD and Fast Track designation for petosemtamab for the treatment of patients with r/m HNSCC whose disease has progressed following ...

The Islamabad High Court (IHC) on Monday sought report from inspector general of police (IGP) regarding alleged illegal arrest of a citizen by the capital police. IHC's Justice Mohsin Akhtar ...